BDH Industries Limited (524828) Fair Value & Analysis
Other · IN · Market cap ₹430M
Fair value as of: Jul 4, 2026
From 17 valuation models · updated 36 days ago
Share price +44.1% over the past month.
A solid business, but screening 51% overvalued on our models.
What matters now
- The price sits above even our optimistic bull case (₹370.08). The favourable scenario is already priced in.
- Solid but not exceptional quality (67/100) and above fair value, neither a clear bargain nor a standout compounder.
- A fairly wide model range (₹174.40 to ₹370.08) leaves room in how you read the outcome.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 4, 2026.
How to read this chart
60‑month range ₹75.64 – ₹514.10 · fair‑value band ₹174.40 – ₹370.08 · the ₹513.80 price screens above the ₹250.78 fair value. Dashed = 300-day average. As of Jul 4, 2026.
Analysis
BDH Industries Limited (524828) currently trades at ₹513.80, while our model-based Fair Value estimate is ₹250.78, implying the stock looks roughly 51.2% overvalued today. The Quality Score stands at 67/100 (solid quality), in the Other sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).
Over the trailing twelve months, BDH Industries Limited generated revenue of ₹522M at a net margin of 10.8%. Revenue grew 18.5% year over year. It earns a return on equity of 14.8%. The stock trades on a trailing P/E of 7.8. Fundamentals as of Jul 4, 2026
Our scenario range runs from ₹174.40 (bear case) to ₹370.08 (bull case); at ₹513.80, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 3% below its 52-week high and 103% above its 52-week low. For context, the median of 10 Other peers we cover trades at -22% fair-value upside, at -51%, 524828 screens richer than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 17 models by family
Widest divergence: DCF Models (₹413.34) versus Dividend Discount (₹57.55). Highest evidence: Residual Income (76).
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 4, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 64 · Market factors (momentum, volatility) 77
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
BDH Industries Limited manufactures and sells therapeutic formulations covering a range of pharmaceuticals in India. It offers analgesic/antipyretic, analgesic balm, antacids, acaricide, anthelmintics, antiprotozoal, aniti-glaucoma, antiseptics, anti-psychotics, anti-tuberculosis, anti-allergics, anti-tussive, antiasthamatics, antibacterial, antiseptic, …
Full company description
BDH Industries Limited manufactures and sells therapeutic formulations covering a range of pharmaceuticals in India. It offers analgesic/antipyretic, analgesic balm, antacids, acaricide, anthelmintics, antiprotozoal, aniti-glaucoma, antiseptics, anti-psychotics, anti-tuberculosis, anti-allergics, anti-tussive, antiasthamatics, antibacterial, antiseptic, anticancer, anticoagulants, anticonvulsants, antidiabetics, anti-emetics, antifungal, antigout, antimalaraial, antiparkinsonisms, antispasmodics, and antiulcer pharmaceutical products. The company also provides antivirals, sedatives/anxiolytics/antidepressants, calcium supplements, cardiovascular products, carminatives/aromatics, corticosteroids, diuretics, drugs acting on uterus, electrolyte replinishers, expextorants, iron supplements, laxatives, local anesthetics, general anesthetics, mydriatics, narcotic-analgesics, non-steroidal anti-inflammatory products, rubefacient and mild analgesics, and pharmaceutical aid products. In addition, it offers skin protectives, skin smootheners, and vitamins, as well as SOULFIL, an oral pill for the treatment of erectile dysfunction in men. The company exports its products to the United States, Canada, Latin America, the Caribbean Islands, Europe, Russia, Gulf Countries, Australia, African countries, Asia, and Far East countries. BDH Industries Limited was founded in 1935 and is based in Mumbai, India.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2022 – FY2026 · reported fiscal years
BDH Industries Limited reported revenue of ₹960M in FY2026 versus ₹694M in FY2022, a compound +8.4%/yr. Reported net income was ₹108M in FY2026, compounding +10.6%/yr from FY2022.
524828 screens 51% overvalued. Compare with Federal Home Loan Mortgage Corporation →
Peer Group
Other · 390 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Other median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
VALUE 0: the price sits above our fair-value range.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Other stocks, each showing price versus our Fair Value estimate (as of Jul 4, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Federal Home Loan Mortgage Corporation FREJO | $15.84 | $52.77 | +233% |
| 533278 533278 | ₹438.60 | ₹720.31 | +64% |
| Nestl?? India Limited 500790 | ₹1,459 | ₹191.93 | -87% |
| 540376 540376 | ₹3,993 | ₹1,806 | -55% |
| 540777 540777 | ₹567.55 | ₹142.69 | -75% |
| Lupin Limited 500257 | ₹2,476 | ₹1,983 | -20% |
| 540719 540719 | ₹1,788 | ₹850.02 | -52% |
| 524804 524804 | ₹1,620 | ₹1,268 | -22% |
| 540716 540716 | ₹1,612 | ₹1,224 | -24% |
| Eicher Motors Limited 505200 | ₹7,340 | ₹6,859 | -7% |
Compare BDH Industries Limited with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
Frequently asked questions
Is BDH Industries Limited (524828) overvalued or undervalued?
What is the fair value of 524828?
What is the quality score of 524828?
What is the revenue of BDH Industries Limited (524828)?
What is the net profit margin of 524828?
Does BDH Industries Limited pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track BDH Industries Limited and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.